Literature DB >> 21036146

Development of experimental cerebral malaria is independent of IL-23 and IL-17.

Hidekazu Ishida1, Chikako Matsuzaki-Moriya, Takashi Imai, Kunio Yanagisawa, Yoshihisa Nojima, Kazutomo Suzue, Makoto Hirai, Yoichiro Iwakura, Akihiko Yoshimura, Shinjiro Hamano, Chikako Shimokawa, Hajime Hisaeda.   

Abstract

Cerebral malaria (CM) is the most severe complication of Plasmodium infection. Although inappropriate immune responses to Plasmodium falciparum are reported as the major causes of CM, the precise mechanisms for development remain unclear. IL-23 and IL-17 have critical roles in the onset of autoimmunity and inflammatory diseases triggered by microbial infections. Thus, we investigated the influence of IL-23 and IL-17 on experimental CM (ECM) using Plasmodium berghei ANKA infection of C57BL/6 mice. Both IL-23 deficient mice and wild-type (WT) mice developed ECM. IL-17 deficient mice also developed ECM, while IL-17 producing cells other than CD4(+) T cells (Th17) were increased in WT mice that developed ECM. In conclusion, this study showed that IL-23 and IL-17 are not involved in ECM development.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036146     DOI: 10.1016/j.bbrc.2010.10.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria.

Authors:  E Ayimba; J Hegewald; A Y Ségbéna; R G Gantin; C J Lechner; A Agosssou; M Banla; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection.

Authors:  Guanfang Shi; David J Field; Kyung-ae Ko; Sara Ture; Kalyan Srivastava; Scott Levy; M Anna Kowalska; Mortimer Poncz; Deborah J Fowell; Craig N Morrell
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

Review 3.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

4.  Co-administration of chloroquine and coenzyme Q10 improved treatment outcome during experimental cerebral malaria.

Authors:  David B Ouko; Peris W Amwayi; Lucy A Ochola; Peninah M Wairagu; Alfred Orina Isaac; James N Nyariki
Journal:  J Parasit Dis       Date:  2022-01-31

5.  IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.

Authors:  Ana Villegas-Mendez; Rachel Greig; Tovah N Shaw; J Brian de Souza; Emily Gwyer Findlay; Jason S Stumhofer; Julius C R Hafalla; Daniel G Blount; Christopher A Hunter; Eleanor M Riley; Kevin N Couper
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

Review 6.  T cell-mediated immunity to malaria.

Authors:  Noah S Butler; John T Harty; Samarchith P Kurup
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

Review 7.  CD4 T-cell subsets in malaria: TH1/TH2 revisited.

Authors:  Damian Perez-Mazliah; Jean Langhorne
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

8.  IL-25, IL-33 and TSLP receptor are not critical for development of experimental murine malaria.

Authors:  Akiko Shibui; Ayako Takamori; Mohammed E M Tolba; Aya Nambu; Eri Shimura; Sachiko Yamaguchi; Chizu Sanjoba; Hajime Suto; Katsuko Sudo; Ko Okumura; Sumio Sugano; Hideaki Morita; Hirohisa Saito; Kenji Matsumoto; Susumu Nakae
Journal:  Biochem Biophys Rep       Date:  2015-12-14

9.  The IL17F and IL17RA Genetic Variants Increase Risk of Cerebral Malaria in Two African Populations.

Authors:  Sandrine Marquet; Ianina Conte; Belco Poudiougou; Laurent Argiro; Sandrine Cabantous; Hélia Dessein; Florence Burté; Aboubacar A Oumar; Biobele J Brown; Abdoualye Traore; Nathaniel K Afolabi; Abdoulaye Barry; Samuel Omokhodion; Ursule Ewanda Ndoumbe; Wuraola A Shokunbi; Olugbemiro Sodeinde; Ogobara Doumbo; Delmiro Fernandez-Reyes; Alain J Dessein
Journal:  Infect Immun       Date:  2015-12-14       Impact factor: 3.441

10.  Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection.

Authors:  João Luiz Silva-Filho; Mariana Conceição Souza; Claudio Teixeira Ferreira-Dasilva; Leandro Souza Silva; Maria Fernanda Souza Costa; Tatiana Almeida Padua; Maria das Graças Henriques; Alexandre Morrot; Wilson Savino; Celso Caruso-Neves; Ana Acacia Sá Pinheiro
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.